Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

Residual cancer after neoadjuvant therapy predicts recurrence years later in men undergoing surgery for high-risk prostate cancer.

Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.

An internal memo was sent from White House budget officials to the U.S. Department of Health and Human Services (HHS). It was dated April 10 and was obtained by CNN.

GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

(HealthDay News) — Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in midlife, according to a study ...

Among male relatives of women with primary ovarian insufficiency, risks for prostate cancer, non-obstructive azoospermia, and severe oligozoospermia were elevated. Non-obstructive azoospermia (NOA ...

(HealthDay News) — Overall cancer mortality rates declined from 2001 through 2022, while cancer incidence rates decreased from 2001 through 2013 and stabilized through 2021, according to the 2024 ...

PROSTOX predicts late genitourinary toxicity, yielding area under the curve of 0.76. (HealthDay News) — A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX ...

Traditional risk factors contribute most to young-onset CIS without patent foramen ovale; nontraditional risk factors more important in CIS with PFO. (HealthDay News) — Traditional risk factors ...

Proposal includes steps that need to be taken to strengthen preparedness, readiness, and health system functions and resilience. (HealthDay News) — Member states of the World Health Organization ...